or
forgot password

    • cancer clinical trials in centralia, IL

    • Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Southern Illinois Hematology/Oncology
    Centralia, Illinois 62801
    Non-small Cell Lung Cancer
    NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
    University Hematology Oncology, Inc
    Centralia, Illinois 62801
    Colorectal Cancer
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    University Hematology Oncology, Inc.
    Centralia, Illinois 62801
    Adenocarcinoma of the Lung
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    University Hematology Oncology, Inc.
    Centralia, Illinois 62801
    Advanced Prostate Cancer, Prostatic Neoplasms
    Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
    Southern Illinois Hematology/Oncology
    Centralia, Illinois 62801
    Breast Cancer, Neutropenia
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Southern Illinois Hematology Oncology
    Centralia, Illinois 62801
    Relapsed Follicular Lymphoma
    Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer
    Southern Illinois Hematology/Oncology
    Centralia, Illinois 62801
    Metastatic Non-small Cell Lung Cancer